Johnson & Johnson's net profit in the first quarter decreased by 14.2%


American Johnson & Johnson, the world's largest manufacturer of medical products, following the results of the first quarter, reported the decline in net profit by 14.2% in annual terms to 3 billion 749 million dollars. Adjusted earnings in the amount of $2.10 cents per share exceeded economists' forecast of 2 dollars 4 cents per share. Revenue figure of 20 billion 21 million dollars grew over the year by only 0.1%, while experts had predicted 19 billion 610 million dollars. During the earnings period, the pharmaceutical business increased sales by 4.1% to 10 billion 244 million dollars. At the same time, the medical equipment division recorded a decline in revenue by 4.6% to $6 billion 549 million. Revenue in the consumer goods division fell by 2.4% to $3 billion 318 million.

The information and recommendations contained in this analytical document are published strictly for information purposes and are not considered as an offer to buy or sell the trading tools mentioned above and are not intended to motivate to perform certain transactions
Something went wrong